This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
Yesterday’s UK 100 Leaders | Price (p) | % Chg |
Entain PLC | 734.8 | 5.7% |
Marks And Spencer Group PLC | 345.0 | 2.9% |
Scottish Mortgage Investment Trust PLC | 1,067.5 | 2.5% |
International Consolidated Airlines Group S.A. | 347.1 | 1.9% |
Glencore PLC | 348.6 | 1.9% |
Yesterday’s UK 100 Laggards | Price (p) | % Chg |
Vodafone Group PLC | 65.1 | -7.0% |
Astrazeneca PLC | 11,030.0 | -2.2% |
Ashtead Group PLC | 5,042.0 | -2.2% |
Compass Group PLC | 2,758.0 | -1.7% |
BAE Systems PLC | 1,210.5 | -1.7% |
Major World Indices | Price | % Chg | 1 YEAR |
UK 100 INDEX | 8,571 | -0.2% | 12.6% |
DOW JONES INDUS. AVG | 44,556 | 0.3% | 16.1% |
DAX INDEX | 21,506 | 0.4% | 27.2% |
NIKKEI 225 | 38,831 | 0.1% | 6.8% |
S&P/ASX 200 INDEX | 8,417 | 0.5% | 10.4% |
Commodities | Units | Price | % Chg |
WTI Crude Oil (Nymex) | USD/bbl. | 72.43 | -0.37% |
Brent Crude (ICE) | USD/bbl. | 75.82 | -0.50% |
Gold Spot | USD/t oz. | 2,858 | 0.6% |
Copper (Comex) | USd/lb. | 437 | 0.5% |
The UK 100 called to open -24 points at 8547. The UK 100 looks set to open slightly lower this morning, having dropped 13 points yesterday.
In Asia this morning The Shanghai Composite was 0.7% lower after China markets reopened following the Lunar New Year holiday. The Hang Seng index has dropped 1.2%.
The Nasdaq and S&P moved higher on Tuesday due to a strong gain in Palantir, as Wall Street sought stable footing following the latest developments on the global trade front. The tech-heavy index jumped 1.35% to 19,654.02, while the S&P 500 rose 0.72% to 6,037.88. The Dow Jones climbed 134.13 points, or 0.3%, to 44,556.04.
GSK today increased its 2031 sales outlook to more than £40 billion, up from £38 billion amid stronger progress in its late-stage drugs pipeline. Total 2024 sales in GSK’s annual results published today were £31.4 billion, a rise of 3%. This improves to 7% at constant exchange rates. Core operating profit rose 11% without currency fluctuations, although the total fell 40% to £4 billion when including a one-off charge of £1.8 billion relating to the settlement of Zantac litigation. GSK sees 2025 turnover growth at constant exchange rates of between 3% to 5%, with core operating profit growth of between 6% to 8%. It declared a dividend of 16p for the fourth quarter and expects to increase the total for 2025 to 64p a share from 61p last year. A £2 billion share buyback programme is set to be implemented over the next 18 months.
No New Broker Comments
UK
DCC (DCC)
GSK (GSK)
Grainger (GRI)
JTC (JTC)
US
Novo Nordisk (NVO) PMO
Uber Technologies (UBER) PMO
The Walt Disney Co (DIS) PMO
ARM Holdings (ARM) AMC
Ford Motor Co (F) AMC
MicroStrategy (MSTR) AMC
Qualcomm Inc (QCOM) AMC
UK
Anglo American (AAL)
AstraZeneca (AZN)
Compass Group (CPG)
Watches of Switzerland Group (WOSG)
US
Bristol-Myers Squibb (BMY) PMO
Eli Lilly and Co (LLY) PMO
Philip Morris International (PM) PMO
Roblox (RBLX) PMO
Amazon.com (AMZN) AMC
Cloudflare (NET) AMC
Illumina (ILMN) AMC
Pinterest (PINS) AMC
Take-Two Interactive Software (TTWO) AMC
Chinese Caixin Services PMI
German HCOB Composite PMI
German HCOB Services PMI
EU HCOB Composite PMI
EU Producer Price Index
US ADP Employment Change
US S&P Global Composite PMI
US ISM Services PMI
US Fed’s Goolsbee speech
UK 100 companies going ex-dividend on 6th February 2025:
None
UK 250 companies going ex-dividend on 6th February 2025:
Paragon Banking Group
Bluefield Solar Income Fund
Aberforth Smaller Companies Trust
GCP Infrastructure Investments
Merchants Trust
Polar Capital Global Financials Trust
Henderson Smaller Cos Inv Tst
Impax Environmental Markets
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.